(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 83.70%159.93B | 70.31%119.49B | 75.98%71.83B | 58.61%34.06B | -14.35%87.06B | -10.62%70.16B | -20.86%40.82B | 1.03%21.47B | 9.81%101.64B | 20.11%78.5B |
Operating income | 83.70%159.93B | 70.31%119.49B | 75.98%71.83B | 58.61%34.06B | -14.35%87.06B | -10.62%70.16B | -20.86%40.82B | 1.03%21.47B | 9.81%101.64B | 20.11%78.5B |
Cost of sales | -49.88%-76.8B | ---- | -47.99%-34.39B | ---- | -12.45%-51.24B | ---- | -2.38%-23.24B | ---- | -21.37%-45.57B | ---- |
Operating expenses | -49.88%-76.8B | -32.59%-106.36B | -47.99%-34.39B | -33.60%-33.29B | -12.45%-51.24B | -3.17%-80.22B | -2.38%-23.24B | -6.22%-24.92B | -21.37%-45.57B | -15.06%-77.75B |
Gross profit | 132.09%83.13B | 230.63%13.14B | 112.97%37.44B | 122.06%761M | -36.12%35.82B | -1,446.05%-10.06B | -39.12%17.58B | -56.25%-3.45B | 1.92%56.08B | 133.62%747M |
Selling expenses | -45.79%-6.35B | -59.91%-4.79B | -59.73%-2.87B | -27.18%-1.33B | 7.44%-4.36B | 19.55%-3B | 21.89%-1.8B | 7.60%-1.05B | 6.03%-4.71B | 2.64%-3.72B |
Administrative expenses | -18.20%-4.15B | -11.77%-2.74B | -20.20%-1.92B | -14.74%-872M | 4.15%-3.51B | 7.36%-2.46B | 9.76%-1.6B | 0.78%-760M | 10.40%-3.66B | 2.86%-2.65B |
Research and development expenses | ---- | -40.67%-377M | ---- | -29.55%-114M | ---- | 10.07%-268M | ---- | -3.53%-88M | ---- | -9.16%-298M |
Profit from asset sales | ---- | 67.11%249M | ---- | 344.44%160M | ---- | 44.66%149M | ---- | -28.00%36M | ---- | -18.25%103M |
Depreciation and amortization | -11.95%-27.17B | ---- | -9.61%-13B | ---- | -0.10%-24.27B | ---- | 2.04%-11.86B | ---- | 1.42%-24.24B | ---- |
Revaluation surplus | ---- | 250.00%574M | ---- | -12.50%21M | ---- | 276.34%164M | ---- | 106.61%24M | ---- | -69.09%-93M |
-Changes in the fair value of other assets | ---- | 250.00%574M | ---- | -12.50%21M | ---- | 276.34%164M | ---- | 106.61%24M | ---- | -69.09%-93M |
Impairment and provision | 127.39%123M | -123.33%-7M | ---- | ---- | 82.71%-449M | 2,900.00%30M | ---- | ---- | 34.44%-2.6B | 107.69%1M |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 34.44%-2.6B | ---- |
-Other impairment is provision | 127.39%123M | -123.33%-7M | ---- | ---- | ---449M | 2,900.00%30M | ---- | ---- | ---- | 107.69%1M |
Special items of operating profit | -55.29%-40.03B | 11.30%3.29B | -41.32%-18.22B | 40.36%866M | 16.30%-25.78B | 1.02%2.96B | 18.20%-12.89B | -10.97%617M | -5.35%-30.8B | 58.99%2.93B |
Operating profit | 124.65%5.56B | 170.72%8.96B | 113.56%1.43B | 86.29%-650M | -127.03%-22.54B | -286.52%-12.67B | -245.57%-10.56B | -22.41%-4.74B | 16.31%-9.93B | 55.43%-3.28B |
Financing income | -21.01%361M | ---- | -12.40%219M | ---- | -32.30%457M | ---- | -34.38%250M | ---- | 109.63%675M | ---- |
Financing cost | 1.30%-5.93B | 37.24%-5.32B | 0.64%-2.97B | 29.93%-817M | 3.16%-6.01B | -127.32%-8.47B | 6.33%-2.99B | 23.79%-1.17B | 7.65%-6.2B | 3.62%-3.73B |
Share of profits of associates | -17,161.54%-2.24B | ---- | 200.00%18M | ---- | -244.44%-13M | ---- | -73.91%6M | ---- | 101.16%9M | ---- |
Share of profit from joint venture company | 79.61%546M | ---- | 86.00%279M | ---- | 12.18%304M | ---- | -3.23%150M | ---- | -12.30%271M | ---- |
Special items of earning before tax | 104.99%187M | -39.36%322M | 62.53%-743M | 14.29%64M | -396.21%-3.75B | 40.85%531M | -437.24%-1.98B | -42.86%56M | -64.14%1.27B | -21.78%377M |
Earning before tax | 95.18%-1.52B | 119.24%3.97B | 88.34%-1.76B | 76.02%-1.4B | -126.82%-31.55B | -210.99%-20.61B | -196.61%-15.13B | -10.29%-5.85B | 8.46%-13.91B | 38.29%-6.63B |
Tax | 33.70%-1.44B | -148.34%-1.2B | -122.81%-717M | -124.47%-321M | -174.84%-2.17B | 62.02%2.47B | 177.25%3.14B | 10.16%1.31B | -14.07%2.89B | -30.37%1.53B |
After-tax profit from continuing operations | 91.23%-2.96B | 115.27%2.77B | 79.30%-2.48B | 62.02%-1.72B | -206.06%-33.72B | -255.59%-18.14B | -202.14%-11.99B | -10.33%-4.54B | 6.86%-11.02B | 40.32%-5.1B |
Earning after tax | 91.23%-2.96B | 115.27%2.77B | 79.30%-2.48B | 62.02%-1.72B | -206.06%-33.72B | -255.59%-18.14B | -202.14%-11.99B | -10.33%-4.54B | 6.86%-11.02B | 40.32%-5.1B |
Minority profit | 216.32%1.18B | 364.60%1.45B | 179.84%396M | 504.65%174M | -193.30%-1.02B | -153.78%-548M | -168.60%-496M | 60.19%-43M | 211.22%1.09B | 194.09%1.02B |
Profit attributable to shareholders | 87.34%-4.14B | 107.51%1.32B | 74.96%-2.88B | 57.78%-1.9B | -170.11%-32.7B | -187.42%-17.59B | -144.99%-11.49B | -12.23%-4.5B | -11.61%-12.11B | 18.01%-6.12B |
Basic earnings per share | 87.89%-0.23 | 106.80%0.07 | 76.47%-0.16 | 62.96%-0.1 | -153.33%-1.9 | -171.05%-1.03 | -126.67%-0.68 | -3.85%-0.27 | 2.60%-0.75 | 30.91%-0.38 |
Diluted earnings per share | 87.89%-0.23 | 104.85%0.05 | 76.47%-0.16 | 62.96%-0.1 | -153.33%-1.9 | -171.05%-1.03 | -126.67%-0.68 | -3.85%-0.27 | 2.60%-0.75 | 30.91%-0.38 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership), KPMG Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data